Incretin Atlas › Molecules › CT-996
CT-996
GLP-1 (small molecule) · oral · Roche
Summary
- Also known as
- Roche / Carmot
- Mechanism
- GLP-1 (small molecule)
- Route
- oral
- Company
- Roche
- Highest development stage
- phase 2
- Status (as of data cut)
- Phase 2 verify
- Next milestone
- Phase 2 readout
Trial arms: weight, HbA1c and tolerability
No trial arms with extracted efficacy or tolerability data yet.
Primary sources
No source recorded.
How to cite this page
Medical Adviser's Group. Incretin Atlas: CT-996. Data cut 12 November 2026. https://docs.mdwrt.app/infographics/incretin-atlas/ct-996/ Data: doi:10.5281/zenodo.23473913. Accessed 16 November 2026.
Cite the primary publication for any single result; every value above links to it.